Skip to main content
Premium Trial:

Request an Annual Quote

Luminex Submits Verigene II Respiratory Assay for FDA Clearance

NEW YORK – Luminex announced Monday that it has applied to the US Food and Drug Administration for 510(k) clearance of the Verigene II Respiratory Flex Assay (RSP Flex), a multiplexed test for simultaneous detection and identification of common viruses and bacteria from nasopharyngeal swabs obtained from a person suspected of having a respiratory tract infection.

The RSP Flex Test uses reverse transcriptase, polymerase chain reaction, and array hybridization to detect specific nucleic-acid gene sequences associated with respiratory viral and bacterial pathogens. The assay runs on Austin, Texas-based Luminex's Verigene II system, a benchtop molecular diagnostic system that uses automation and specialized chemistry to enable rapid, sample-to-result detection.

In the fourth quarter of last year, Luminex also applied to the FDA for clearance of its Gastrointestinal Flex Assay for the detection and identification of enteric bacteria, viruses, parasites, and toxins in stool samples.

Luminex said it anticipates launching the system and assays in the middle of this year.

Luminex President and CEO Nachum Shamir said in a statement that the "flexibility of the automated Verigene II system uniquely allows clinical laboratories to select, test, and pay for only the targets ordered for each patient."

The Scan

Study Tracks Off-Target Gene Edits Linked to Epigenetic Features

Using machine learning, researchers characterize in BMC Genomics the potential off-target effects of 19 computed or experimentally determined epigenetic features during CRISPR-Cas9 editing.

Coronary Artery Disease Risk Loci, Candidate Genes Identified in GWAS Meta-Analysis

A GWAS in Nature Genetics of nearly 1.4 million coronary artery disease cases and controls focused in on more than 200 candidate causal genes, including the cell motility-related myosin gene MYO9B.

Multiple Sclerosis Contributors Found in Proteome-Wide Association Study

With a combination of genome-wide association and brain proteome data, researchers in the Annals of Clinical and Translational Neurology tracked down dozens of potential multiple sclerosis risk proteins.

Quality Improvement Study Compares Molecular Tumor Boards, Central Consensus Recommendations

With 50 simulated cancer cases, researchers in JAMA Network Open compared molecular tumor board recommendations with central consensus plans at a dozen centers in Japan.